What is Yues International Holdings Group Limited stock?

Yues International Holdings Group Limited (1529.HK) Business Introduction

Yues International Holdings Group Limited (formerly known as Goal Rise Logistics (China) Holdings Limited) is a leading integrated logistics service provider based in China. The company specializes in providing end-to-end supply chain solutions, particularly for manufacturing enterprises in high-growth sectors such as medicine, fast-moving consumer goods (FMCG), and health and beauty.

Business Modules

1. Transportation Services: This is a core segment involving the delivery of production materials or components from suppliers to manufacturing plants. It also manages the distribution of finished goods to designated locations or downstream customers. The company has expanded into sea transportation and international freight forwarding to support global supply chains.

2. Warehousing Services: Yues provides sophisticated inventory storage and management. Their facilities are equipped with temperature and humidity control, advanced security systems (CCTV), and pest control, meeting high regulatory standards for sensitive industries like pharmaceuticals.

3. In-Plant Logistics: A specialized service where Yues manages logistics within the customer's own manufacturing facility. This includes managing the movement of raw materials to production lines and transporting finished goods to the factory gate.

4. Customization Services: Value-added services such as labeling, bundling, and specialized packaging that help customers prepare products for specific market requirements or retail promotions.

5. Diversified Sales (New): Recently, the company has diversified into the sales of goat milk powder and other health-related products, leveraging its logistics network to enter the consumer goods market.

Commercial Model Characteristics

Full-Chain Integration: Unlike simple "point-to-point" trucking companies, Yues integrates itself into the customer's manufacturing process (In-Plant) and sales preparation (Customization), creating high switching costs for clients.
Focus on Sensitive Goods: By specializing in goods that require strict environmental controls (e.g., medicine and health products), the company earns higher margins than general commodity transporters.

Core Competitive Moat

Operational SOPs and Training: The company utilizes a rigorous set of Standard Operating Procedures (SOPs) and safety management systems that are crucial for high-quality manufacturing clients.
Proprietary IT Integration: Yues uses advanced logistics management systems that provide real-time tracking and inventory management, allowing for rapid response to demand fluctuations.

Latest Strategic Layout

Strategic Acquisitions: In 2024 and 2025, the company aggressively pursued acquisitions, such as the 100% equity interest in Hangzhou Yihang Logistics Co., Ltd. (expected completion by May 31, 2026), to expand its geographic footprint and market share.
Expansion into Chinese Medicine: As of mid-2025, the group reallocated approximately HK$20 million of its proceeds to support the development of its Chinese medicine business, signaling a pivot toward higher-value health sectors.

Yues International Holdings Group Limited Development History

Development Characteristics

The company’s history is defined by its transition from a regional logistics player to a diversified international holding group listed on the Main Board of the SEHK. It has successfully navigated the shift from the GEM board to the Main Board, reflecting its growth in scale and governance.

Detailed Phases of Development

1. Founding and Regional Expansion (1996 - 2016): Founded in 1996, the company initially focused on domestic logistics within China, building a reputation for reliability in the Guangdong province, a major manufacturing hub.

2. Public Listing and Professionalization (2017 - 2019): In October 2017, the company (then Goal Rise Logistics) successfully listed on the GEM board (Stock Code: 8457). This period focused on standardizing operations and expanding its warehousing capacity. In December 2019, it successfully transferred its listing to the Main Board of the Stock Exchange of Hong Kong (Stock Code: 1529).

3. Rebranding and Diversification (2022 - 2024): In May 2022, the company officially changed its name to Yues International Holdings Group Limited to reflect a broader business vision beyond just logistics. It began diversifying into the health and consumer goods sectors, including the sale of goat milk powder.

4. Strategic Restructuring and New Sectors (2025 - Present): Following a challenging 2023-2024 (reporting a net loss of approximately RMB 34.2 million in FY2023), the company initiated an internal reorganization in late 2024. This involved combining complementary divisions and investing heavily in the Chinese medicine sector and strategic logistics acquisitions to restore profitability.

Success and Challenge Analysis

Success Factors: Strong penetration into the pharmaceutical and FMCG supply chains which provided stable recurring revenue during growth phases; successful migration to the SEHK Main Board which improved access to capital.
Challenges: Recent years (2023-2025) saw headwinds due to rising lease costs and impairments. The company is currently in a "turnaround" phase, focusing on high-margin health products to offset the lower margins in traditional transportation.

Industry Introduction

Industry Landscape and Trends

The logistics and supply chain industry in China and Hong Kong is moving toward digitalization and specialization. There is an increasing demand for "Smart Logistics" and cold-chain capabilities driven by the pharmaceutical and e-commerce sectors.

Competitive Landscape

The industry is highly fragmented, ranging from global giants to small local truckers. Yues International occupies a mid-tier specialized niche. Unlike giants that focus on volume, Yues competes on customized service depth (e.g., the In-Plant segment).

Industry Status and Characteristics

Market Position: Yues is recognized as a sophisticated "LSP" (Logistics Service Provider) for the "Big Health" industry. Its ability to handle sensitive goods according to strict fire and safety regulations sets it apart from general logistics firms.
Future Catalyst: The 2024/2025 focus on the Northern Metropolis development and the GBA plan provides a massive tailwind for logistics providers that can integrate transport with value-added warehousing and processing.

Yues International Holdings Group Limited Financial Health Score

Based on the audited results for the 2024 fiscal year and the latest unaudited performance indicators for 2025, the financial health of Yues International is characterized by stabilizing revenue but persistent bottom-line pressure as it transitions its business model.

Yues International Holdings Group Limited Development Potential

Strategic Transformation into Big Health

The company has actively shifted its focus from pure-play logistics to the "Big Health" sector. A major catalyst in early 2026 was the reallocation of HK$ 15.26 million from unutilized rights issue proceeds toward traditional Chinese medicine (TCM) and goat milk products. This move aims to leverage their existing logistics infrastructure to create a vertically integrated health product distribution network.

M&A and Infrastructure Expansion

Yues International has recently pursued strategic acquisitions to bolster its supply chain capabilities. Notable events include:
• Acquisition of Hangzhou Yihang Logistics: Agreed in early 2026 to acquire 100% of this entity to gain valuable customer resources and specialized licenses.
• Pharma Distribution Entry: The 2025 acquisition of Bozhou Lelaohao Medical Co., Ltd. (which holds a Pharmaceutical Operation Permit) serves as a foundational step for their wholesale pharmaceutical distribution business.

E-commerce and Digital Integration

The roadmap for 2025-2026 emphasizes the development of an e-commerce footprint. By integrating its logistics expertise with a digital sales platform for goat milk and TCM, the company seeks to improve margins compared to traditional B2B logistics services.

Yues International Holdings Group Limited Pros and Risks

Investment Pros (Positive Catalysts)

• Diversified Revenue Streams: The pivot into high-demand sectors like TCM and premium goat milk reduces reliance on the cyclical logistics industry.
• Strong Asset Management: The company has shown agility in reallocating capital (rights issue proceeds) toward higher-growth areas.
• Undervalued Potential: Trading at a Market Cap of approximately HK$ 300M - 330M, the stock may offer upside if the Big Health business achieves profitability.

Investment Risks (Potential Drawbacks)

• Sustained Net Losses: Despite rising revenues, the company has remained unprofitable over several reporting periods, with a negative ROE of approximately -14.5%.
• Execution Risk in New Markets: The transition from logistics to pharmaceutical and health product sales requires different regulatory expertise and marketing capabilities.
• Market Volatility: The stock has historically experienced significant price fluctuations (over 10% intraday moves), reflecting thin trading volumes and sensitive market sentiment.

How do Analysts View Yues International Holdings Group Limited and 1529 Stock?

As of early 2024, market sentiment toward Yues International Holdings Group Limited (Stock Code: 1529.HK) reflects a company in a state of strategic transition. Formerly known as Goal Forward Holdings Limited, the group has shifted its focus from its historical roots in food supply to the high-growth sectors of cross-border e-commerce and logistics infrastructure. Analysts tracking the Hong Kong small-cap sector view the company as a high-risk, high-reward play, characterized by significant business restructuring and volatility.

1. Core Institutional Perspectives on the Company

Strategic Pivot to E-commerce: Analysts note that the company’s rebranding to Yues International signifies a definitive move into the digital economy. By leveraging its logistics background, the company aims to capture margins in the cross-border trade between mainland China and international markets. Markets view this as a necessary move to escape the low-margin constraints of traditional food wholesaling.
Asset-Light Growth Strategy: Recent financial reviews highlight the company’s efforts to optimize its balance sheet. Analysts have observed a shift toward "platform-based" services rather than capital-intensive traditional warehousing. This transition is intended to improve Return on Equity (ROE) over the long term, though execution remains the primary focus of skepticism.
Supply Chain Resilience: Despite global macro headwinds, Yues International has maintained a stable footprint in the Guangdong-Hong Kong-Macao Greater Bay Area. Analysts credit the company’s localized logistics expertise as a "moat" that protects its core operations while it explores new digital revenue streams.

2. Stock Performance and Market Sentiment

The market consensus for 1529.HK remains cautious, as the stock is primarily tracked by boutique research firms and local institutional desks specializing in Hong Kong small-caps:
Valuation Multiples: Based on the 2023/2024 fiscal data, the stock trades at a Price-to-Earnings (P/E) ratio that reflects significant market uncertainty regarding its earnings consistency. Analysts point out that the Price-to-Book (P/B) ratio remains relatively low compared to tech-logistics peers, suggesting the stock may be undervalued if the e-commerce transition proves successful.
Liquidity Constraints: A common point of analysis is the stock’s low trading volume. Market analysts warn that 1529.HK is subject to high volatility and "slippage," making it more suitable for long-term strategic investors rather than short-term traders.
Earnings Quality: Recent interim reports showed a fluctuation in net profit margins. Analysts are closely watching for "stabilization" in the next few quarters to confirm that the costs associated with business restructuring have been fully absorbed.

3. Key Risk Factors Identified by Analysts

While the company’s turnaround plan is ambitious, analysts highlight several critical risks:
Intense Competitive Landscape: The cross-border e-commerce sector is dominated by giants. Analysts question whether a smaller player like Yues International can maintain pricing power without significant capital expenditure.
Regulatory Compliance: Operating in international trade subjects the company to complex customs regulations and trade policies. Any shifts in international trade relations could impact the volume of goods flowing through their logistics network.
Macroeconomic Sensitivity: As a service provider to the consumer retail sector, Yues’s revenue is highly sensitive to consumer confidence in the Greater Bay Area. Analysts note that a slowdown in regional consumption would directly impact their bottom line.

Summary

The prevailing view among market observers is that Yues International Holdings Group Limited is a company in a "wait-and-see" phase. While the shift toward digital logistics and e-commerce provides a clear path for growth, the stock (1529) remains a speculative investment until the company can demonstrate sustained revenue growth and improved profit margins from its new business segments. Investors are advised to monitor the upcoming 2024 annual results for evidence of operational efficiency gains.

Yues International Holdings Group Limited (1529.HK) FAQ

What are the investment highlights of Yues International Holdings Group Limited, and who are its main competitors?

Yues International Holdings Group Limited (formerly Goal Rise Logistics (China) Holdings Limited) is an investment holding company primarily engaged in providing integrated logistics services in China. Its core business segments include transportation, warehousing, in-plant logistics, and customization services (such as labeling and bundling).

Investment Highlights:
1. Strategic Diversification: The company has recently expanded into the "Big Health" sector, including traditional Chinese medicine and goat milk products, to diversify its revenue streams beyond traditional logistics.
2. Strategic Acquisitions: In early 2026, the group announced the acquisition of Hangzhou Yihang Logistics to strengthen its e-commerce and logistics footprint in mainland China.
3. Operational Stability: It serves diverse industries such as beverages, textiles, pharmaceuticals, and FMCG, providing a degree of sector-based resilience.

Main Competitors:
The company competes with other regional and specialized logistics providers in the Hong Kong and China markets, including World-Link Logistics (Asia) Holding (6083.HK), Infinity Logistics and Transport Ventures (1442.HK), and Changan Minsheng APLL Logistics (1292.HK).

Is the latest financial data for Yues International Holdings Group Limited healthy? What are the revenue, net profit, and debt conditions?

Based on the latest reports for the fiscal year ending December 31, 2025, the company's financial performance shows signs of narrowing losses but remains under pressure:
- Revenue: Reported at approximately CNY 343.2 million for FY2025.
- Net Profit/Loss: The company recorded a net loss of approximately CNY 22.9 million to CNY 24.2 million. This was an improvement compared to the CNY 0.19 loss per share in FY2024, as the loss per share narrowed to CNY 0.042 in 2025.
- Debt Situation: The company maintains a relatively low-risk balance sheet with a very low debt-to-equity ratio (reported near 0% or 1.79% depending on the reporting period), indicating it is largely debt-free. Short-term assets (CNY 209M) significantly exceed short-term liabilities (CNY 32.1M).

Is the current 1529 stock valuation high? How do the P/E and P/B ratios compare to the industry?

As the company has been reporting net losses, traditional valuation metrics like the P/E ratio are negative, making them less useful for standard comparison:
- Price-to-Earnings (P/E) Ratio: Approximately -10.2x to -12.4x (TTM), reflecting the current lack of profitability compared to an industry average that typically sits around 11x.
- Price-to-Book (P/B) Ratio: Currently around 1.69x to 1.90x. This is generally in line with or slightly higher than some industry peers, suggesting the market still assigns value to its underlying assets and strategic pivots.
- Price-to-Sales (P/S) Ratio: Approximately 0.8x to 1.03x, which is lower than the industry average of roughly 1.48x, potentially indicating the stock is undervalued relative to its sales volume.

How has the 1529 stock price performed over the past three months and year? Has it outperformed its peers?

The stock has experienced significant volatility over the past year:
- One-Year Performance: As of April 2026, the stock has shown a strong recovery from its lows, with a 1-year return of approximately 32.5% to 130% (depending on the specific timeframe measured), outperforming the broader Hong Kong market (approx. 19.6%) and the Hong Kong logistics industry (approx. 36.3%).
- Three-Month Performance: More recently, the stock has faced a downward trend, dropping approximately 8.9% to 14% over the last three months.
- 52-Week Range: The stock has traded between HK$0.224 and HK$0.640.

Are there any major institutional movements or recent news affecting 1529 stock?

Recent News:
- Change in Use of Proceeds: In April 2026, the board approved redeploying HK$15.26 million from a prior rights issue (originally for a goat milk project) into a broader "Big Health" portfolio, including traditional Chinese medicine.
- Acquisition: The group is finalizing the acquisition of Hangzhou Yihang Logistics for a nominal consideration (RMB 10,000) while assuming strategic customer resources and licenses.

Institutional/Insider Activity:
- There has been substantial shareholder dilution over the past year, with total shares outstanding increasing significantly (up to 400% reported in some analysis) due to corporate actions. Currently, there is insufficient data to confirm major new institutional "buys" in the most recent quarter, and the stock is not widely covered by major investment bank analysts.